FTO mutant, adeno-associated virus and application of FTO mutant and adeno-associated virus in preparation of medicine for treating osteoporosis
CN119020306APending Publication Date: 2024-11-26THE AFFILIATED SIR RUN RUN SHAW HOSPITAL OF SCHOOL OF MEDICINE ZHEJIANG UNIV
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CN202411051378.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-01
- Publication Date
- 2024-11-26
Smart Images

Figure CN119020306A_ABST
Abstract
The invention discloses an FTO mutant, an adeno-associated virus and application of the FTO mutant and the adeno-associated virus in preparation of a medicine for treating osteoporosis. The 216th site, the 357th site and the 365th site in the FTO mutant are mutated into arginine from lysine, and the FTO mutant has the capability of inducing osteoblast differentiation in vitro; the adeno-associated virus AAV-FTO-3KR can be prepared from the adeno-associated virus AAV-FTO-3KR and can be applied to preparation of drugs for preventing or treating osteoporosis. The application disclosed by the invention has great influence on research and treatment of the enteritis-related osteoporosis diseases, has certain potential clinical practical value, and opens up a new clinical application for the FTO protein. The invention develops FTO related mutants and adeno-associated viruses, belongs to preclinical medication, expands the disease application field of the FTO protein mutants, has the advantages of less dosage and small side effect compared with the conventional dosage, and simultaneously has the application prospect of drugs for treating other types of osteoporosis.
Need to check novelty before this filing date? Find Prior Art
